483
The Procter & Gamble Manufacturing CompanyFDA 483 - The Procter & Gamble Manufacturing Company - November 17, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
The FDA inspected The Procter & Gamble Manufacturing Company in Greensboro, NC, an OTC drug manufacturer. The inspection revealed significant deficiencies across multiple areas, including a lack of process validation for packaging and labeling, inadequate supplier qualification, and poor complaint handling procedures. Additionally, the firm failed to properly maintain and sanitize equipment and utensils, leading to potential contamination risks.
Open in Dashboard
ID · 7135b04c-f517-4517-88cd-2dc0c2af670b